Category: Campaigns

A Civil Society Response to the Big Pharma wish list in TTIP

The analysis of the most worrying proposals of the pharmaceutical industry's wish list for the EU-US trade agreement reveals a real threat to European public health systems and democracy. 

Joint position paper produced by Commons Network in cooperation with Medicines in Europe Forum (MiEF), International Society of Drug Bulletins (ISDB), Health Action International Europe (HAI-Europe), Universities Allied for Essential Medicines - Europe (UAEM-Europe), Salud por Derecho Foundation and The Working Group on Health, Medicines & Innovation (GTSMI).

Read more...

EMA’s final policy on access to clinical data: proactive access to some data, but strings attached

On 2 October 2014, the European Medicines Agency (EMA) finally adopted its policy on access to clinical data. From 1 January 2015 onwards, the general public will be able to “view on screen” selected parts of trial reports submitted in support of marketing authorisations, and academic and non-commercial researchers will be allowed to download this data. The policy, unfortunately, also gives pharmaceutical companies the upper hand in deciding the contents of the clinical reports by allowing them to redact data on the grounds of “commercial confidentiality”. The implementation of the policy will need careful monitoring. 

Read more...